Hospital-acquired infection

Mile Bluff Medical Center Now Live with MEDITECH Expanse Search and Summarization, Powered by Google Health

Retrieved on: 
Thursday, February 8, 2024
Managed Care, Software, Hardware, Data Management, Technology, Medical Devices, Hospitals, Genetics, Artificial Intelligence, Nanotechnology, Nursing, Practice Management, Health, Cloud, Hospital-acquired infection, ED, MD, Collaboration, Sepsis, Intelligence, Pharmacy, Coffee, Infection, DNR, HIM, Google Health, Multimedia, OB, HIMSS, Patient, Water, Physician, MEDITECH, CMO, Clinic, Workflow

Mile Bluff Medical Center (Mauston, WI) just took a significant step forward in reducing clinician burdens by going live with MEDITECH’s new AI-powered Expanse search and summarization capabilities powered by Google Health.

Key Points: 
  • Mile Bluff Medical Center (Mauston, WI) just took a significant step forward in reducing clinician burdens by going live with MEDITECH’s new AI-powered Expanse search and summarization capabilities powered by Google Health.
  • Mile Bluff’s Expanse EHR uses Google Health’s advanced summarization capabilities to synthesize and organize this data, giving clinicians timely and intuitive access to a more holistic view of patients and their conditions.
  • “Our providers saw an immediate impact upon going live with the search and summarization functionality,” explains Randy Brandt, PA-C, a primary care physician assistant and team lead for the project.
  • “They appreciated how they can launch the functionality directly from their Expanse Chart Viewer to get a complete longitudinal view of their patients.

North Star Vascular & Interventional Opens New Center in Minneapolis

Retrieved on: 
Wednesday, December 20, 2023
Technology, FDA, Health, Robotics, Other Health, Radiology, Surgery, Oncology, Practice Management, Medical Devices, Managed Care, General Health, Hospitals, Health Technology, Patient, Google Images, Varicocele, Artery, Pain management, Peripheral artery disease, Risk, Advocate Christ Medical Center, Knee, Physician, Uterine fibroid, Vascular disease, Intervention, Male, Infertility, Kidney disease, Chronic pain, Thyroid disease, Osteoarthritis, MBA, MD, Vein, Cancer, GE HealthCare, University, Moyamoya disease, Neoplasm, Rush University Medical Center, Fibroid, Interventional radiology, Liver cancer, Hospital-acquired infection, Pelvic congestion syndrome, Radiation, Y-90, Medical imaging

The field of vascular and interventional radiology is growing, and three area physicians have opened an outpatient center to provide viable alternatives to hospital-based surgery in Golden Valley.

Key Points: 
  • The field of vascular and interventional radiology is growing, and three area physicians have opened an outpatient center to provide viable alternatives to hospital-based surgery in Golden Valley.
  • North Star Vascular & Interventional (NSVI) offers minimally invasive procedures to treat health conditions such as peripheral artery and venous disease, cancer, enlarged prostate, uterine fibroids and more.
  • Jafar Golzarian, MD, FSIR, professor emeritus of interventional radiology at the University of Minnesota Medical School, has authored more than 400 academic articles and national and international lectures on interventional radiology.
  • Bulent Arslan, MD, FSIR is a Professor of Radiology and Chief of Interventional Radiology at the Rush University Medical Center in Chicago.

Hospital Air Purifiers Global Market Outlook Report 2023, with Profiles of Key Players Daikin, Honeywell, IQAir, Koninklijke Philips and More - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 28, 2023
Health, Hospitals, World Health Organization, Carbon, Research, Air pollution, Investment, Hospital, Nature, Hospital-acquired infection, COVID-19, Porter's five forces analysis, HEPA, IQAir, PESTLE, Ambulance, Daikin, ESG, Medical device, Pharmaceutical industry, Marketing

Hospital air is polluted by a variety of substances that are organic as well as inorganic in nature.

Key Points: 
  • Hospital air is polluted by a variety of substances that are organic as well as inorganic in nature.
  • Hospital air can lead to many problems; Hence, it is imperative to monitor as well as control hospital and healthcare air quality.
  • New hospitals require a well-established ventilation system equipped with high-quality air filters and purifiers, which will drive the market.
  • The report provides market data and forecasts for the air purifier market by product type, including HEPA and non-HEPA filters.

Hospital Air Purifiers Market Industry Report - Market Revenue Data for 2022, Estimates for 2023, Forecasts and CAGR Projections for 2024 through 2028

Retrieved on: 
Friday, November 24, 2023
World Health Organization, Carbon, Research, Air pollution, Investment, Hospital, Nature, Hospital-acquired infection, Health, COVID-19, Porter's five forces analysis, HEPA, PESTLE, Ambulance, ESG, Medical device, Pharmaceutical industry, Tissue paper, Marketing

Hospital air is polluted by a variety of substances that are organic as well as inorganic in nature.

Key Points: 
  • Hospital air is polluted by a variety of substances that are organic as well as inorganic in nature.
  • Hospital air can lead to many problems; Hence, it is imperative to monitor as well as control hospital and healthcare air quality.
  • New hospitals require a well-established ventilation system equipped with high-quality air filters and purifiers, which will drive the market.
  • The report provides market data and forecasts for the air purifier market by product type, including HEPA and non-HEPA filters.

Genesis MedTech introduces China's first domestic brand of NPMA-approved antibacterial sutures

Retrieved on: 
Tuesday, September 12, 2023
Triclosan, Suture, Staphylococcus, Staphylococcus epidermidis, Infection, MRSA, Gram-negative bacteria, Hospital-acquired infection, Staphylococcus aureus, CDC, MRSE, Patient, Risk, Korea Disease Control and Prevention Agency, Perioperative, National Medical Products Administration, Growth, Methicillin-resistant Staphylococcus aureus, WHO, JAMA Surgery, Lancet, NMPA, Genesis, Dis, World Health Organization, Pharmaceutical industry, Vaccine

The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and gram-negative bacteria.

Key Points: 
  • The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and gram-negative bacteria.
  • Alongside the highly anticipated absorbable antibacterial sutures, Genesis MedTech continues to expand its suture product lines with comprehensive offerings.
  • Furthermore, its barbed absorbable sutures with black needle, non-absorbable surgical polypropylene sutures, and controlled-release needle sutures have been widely used in thousands of hospitals nationwide.
  • Warren Wang, Chairman and CEO of Genesis MedTech Group, expressed his excitement stating, "We are thrilled to achieve this significant milestone as the first domestic brand in China to develop antibacterial sutures.

Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices

Retrieved on: 
Wednesday, September 6, 2023
Hospital-acquired infection, DEB, Medicine, Minocycline, RM, Rifampicin, Mastectomy, Pain management, Growth, Defibrillation, Wound healing, Medical device

SILVER SPRING, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) today announced a change of the Company’s name to Elutia Inc. The rebranding reflects the strategic focus to develop and commercialize proprietary drug-eluting biomatrix technology aimed at improving surgical outcomes. The name change becomes effective today, September 6, 2023. The Company’s stock will begin trading on Nasdaq under the new ticker symbol “ELUT” on September 7, 2023.

Key Points: 
  • SILVER SPRING, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) today announced a change of the Company’s name to Elutia Inc.
  • The rebranding reflects the strategic focus to develop and commercialize proprietary drug-eluting biomatrix technology aimed at improving surgical outcomes.
  • “We are excited to introduce Elutia, where we exist to humanize medicine by pioneering drug-eluting biomatrix or DEB technology,” said Dr. Randy Mills, President and Chief Executive Officer of Elutia.
  • To address this, Elutia is developing SimpliDerm® RM incorporating our proprietary DEB technology.

Aseptiscope Announces Upcoming Growth Funding Round for Commercialization Of DiskCover Stethoscope Hygiene System

Retrieved on: 
Thursday, August 31, 2023
Infection, Stethoscope, University, Heart failure, Hand, Clean, Face, Workflow, SAN, Health care, COVID-19, Diaphragm, Hospital-acquired infection, Hygiene, UC, MD, Patient, Risk, Series, University of California, Irvine, BNP, Bacteria, Fungal infection, Death, Safety, Medical device, Medicine

Aseptiscope® , a California-headquartered medical innovation startup, has announced that it will soon open its Series B/growth funding round, in preparation for the commercialization of its DiskCover™ stethoscope hygiene system.

Key Points: 
  • Aseptiscope® , a California-headquartered medical innovation startup, has announced that it will soon open its Series B/growth funding round, in preparation for the commercialization of its DiskCover™ stethoscope hygiene system.
  • While there has been significant attention on hand hygiene, especially after the COVID-19 pandemic, stethoscope hygiene has been relatively unnoticed.
  • It is working on the prototypes for a touch-free hand hygiene system and an ultrasound probe barrier system.
  • “ Aseptiscope is now on the precipice of commercializing its innovative DiskCover system, in the face of an enormous unmet need regarding stethoscope contamination,” Mader says.

TurnCare partners with Monetize360 to effectively scale its Patient Management Solution, driving revenue and increasing customer satisfaction

Retrieved on: 
Wednesday, August 23, 2023
Cloud, Intelligence Support Battalion, Internet of things, Hospital, Hospital-acquired infection, Johnson Health Tech, Patient management software, Blood, Association of British HealthTech Industries, Patient, LOS, Nursing, 3D printing

LOS ALTOS, Calif., Aug. 23, 2023 /PRNewswire-PRWeb/ -- TurnCare has selected Monetize360, a leading Agile Monetization company, to drive, support, and enable utilization-driven billing data capture for their first-of-its-kind Intelligent Support Surface Patient Management Solution. The company chose Monetize360 because of its singular ability to handle the challenges of complex, usage-based billing models at scale without requiring intensive engineering resources.

Key Points: 
  • The company chose Monetize360 because of its singular ability to handle the challenges of complex, usage-based billing models at scale without requiring intensive engineering resources.
  • Hospitals only pay for TurnCare when they use it for specific patients.
  • With an intuitive front end, almost anyone within TurnCare can analyze revenue in moments instead of days to weeks.
  • Since deploying Monetize360, we've seen a significant uptick in revenue and increased customer satisfaction.

IDTechEx Discusses Applications of Antimicrobial Technology in Addressing Healthcare Infections

Retrieved on: 
Monday, July 17, 2023
Hand, HAI, Health care, Silver, Clothing, Infection, Research, Temperature, Hospital-acquired infection, Fungus, Houston, Humidity, Hospital, Patient, Sport, Fungal infection, Bacteria, Copper, Health, Textile, Hypercallia cuprones, Skin, Antibiotics

IDTechEx has recently published a market research report on the topic, ' Antiviral and Antimicrobial Technology Market 2023-2033 ', examining the technologies, applications, and drivers for the antimicrobial technology industry.

Key Points: 
  • IDTechEx has recently published a market research report on the topic, ' Antiviral and Antimicrobial Technology Market 2023-2033 ', examining the technologies, applications, and drivers for the antimicrobial technology industry.
  • One of the key motivations for companies interviewed by IDTechEx is the development of antimicrobial technology to address the problem of HAIs.
  • Though hundreds of companies are developing antimicrobial technology and thousands upon thousands of antimicrobial products, not all antimicrobials are created equal.
  • To find out more about the IDTechEx report 'Antiviral and Antimicrobial Technology Market 2023-2033', including downloadable sample pages, please visit www.IDTechEx.com/antimicrobial .

IDTechEx Discusses Applications of Antimicrobial Technology in Addressing Healthcare Infections

Retrieved on: 
Monday, July 17, 2023
Hand, HAI, Health care, Silver, Clothing, Infection, Research, Temperature, Hospital-acquired infection, Fungus, Houston, Humidity, Hospital, Patient, Sport, Fungal infection, Bacteria, Copper, Health, Textile, Hypercallia cuprones, Skin, Antibiotics

IDTechEx has recently published a market research report on the topic, ' Antiviral and Antimicrobial Technology Market 2023-2033 ', examining the technologies, applications, and drivers for the antimicrobial technology industry.

Key Points: 
  • IDTechEx has recently published a market research report on the topic, ' Antiviral and Antimicrobial Technology Market 2023-2033 ', examining the technologies, applications, and drivers for the antimicrobial technology industry.
  • One of the key motivations for companies interviewed by IDTechEx is the development of antimicrobial technology to address the problem of HAIs.
  • Though hundreds of companies are developing antimicrobial technology and thousands upon thousands of antimicrobial products, not all antimicrobials are created equal.
  • To find out more about the IDTechEx report 'Antiviral and Antimicrobial Technology Market 2023-2033', including downloadable sample pages, please visit www.IDTechEx.com/antimicrobial .